Pacira BioSciences, Inc. Common Stock PCRX
$36.39
+44.40%
at last close
Financials (TTM)
- Revenue
- $746.16 million
- Net Income
- $14.64 million
- Net Margin
- 1.96%
- Return on Equity
- 2.18%
- Debt-to-Equity
- 0.54
- P/E Ratio
- 103.97
- Price / Book
- 1.49
- Price / Sales
- 1.35
Over the trailing twelve months, Pacira BioSciences, Inc. Common Stock generated revenue of $746.16 million and net income of $14.64 million, a net margin of 1.96%.
At the last closing price of $36.39, PCRX trades at 103.97 times trailing earnings and 1.35 times sales, with a market capitalization of $1.00 billion.
Key Stats
- Last Close
- $36.39
- Market Cap
- $1.00 billion
- 52-Week Range
- $18.80 – $36.46
- Average Volume
- 1.50 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.